Applying the 5 % cream to large facial areas is sometimes done under specialist supervision, but the risk of severe irritation and systemic absorption increases. A dermatologist will typically start with a lower concentration or treat in stages to minimise adverse effects.
The inflammatory phase usually peaks at 1-2 weeks and may last up to 4 weeks. Redness and peeling gradually improve over the following weeks as new, healthy skin replaces the treated tissue.
Because the medication can cause extensive skin ulceration, it is advisable to inform surgeons or proceduralists ahead of time. They may postpone elective surgeries until the treated area has healed.
Topical fluorouracil has minimal systemic absorption, so it generally does not interfere with anticoagulants. Nevertheless, discuss all current medications with your prescriber to ensure safety.
Yes, after the cream has been absorbed (typically 30 minutes), applying a broad-spectrum sunscreen protects the surrounding skin from further UV damage and may reduce irritation.
Immediately rinse the eyes with plenty of water for at least 15 minutes and seek urgent medical attention, as fluorouracil can cause significant ocular irritation.
No specific dietary changes are required. Maintaining a balanced diet supports overall skin health, but avoid excessive alcohol if you are also receiving systemic chemotherapy.
Both are topical treatments, but they work via different mechanisms: Efudex directly kills abnormal cells, while imiquimod stimulates the immune response. Efficacy, side-effect profiles, and treatment duration differ, and the choice depends on lesion characteristics and patient preference.
Yes, but carry the prescription label and a copy of the prescribing information. Some countries may require documentation for import of prescription topical agents; check the destination’s regulations before travel.
Efudex is a brand-name topical medication that contains fluorouracil as its active ingredient. It is supplied in a tube and is available in two strengths: 1 % and 5 %. Fluorouracil belongs to the class of antimetabolite agents and is used primarily in dermatology to treat pre-cancerous and early-stage skin lesions. In the United Kingdom, Efudex is a prescription-only medicine (Rx) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Fluorouracil is a pyrimidine analog that interferes with DNA synthesis. When applied to the skin, it is taken up by rapidly dividing keratinocytes, where it is converted to fluoro-deoxyuridine monophosphate (FdUMP). FdUMP blocks the enzyme thymidylate synthase, preventing the formation of thymidine nucleotides required for DNA replication. The resulting disruption leads to cell death (apoptosis) of abnormal skin cells while sparing most normal tissue. Onset of action typically begins within a few days, with maximal skin reaction occurring 1-2 weeks after starting treatment. The drug remains largely confined to the area of application, resulting in minimal systemic absorption.
Both indications are approved by the MHRA for use of the 5 % fluorouracil formulation. The 1 % strength may be prescribed for sensitive areas or for patients who require a gentler regimen, although this is less common and typically considered an off-label concentration.
Disclaimer: Off-label use of Efudex requires supervision by a qualified healthcare professional and an individualized risk-benefit assessment.
Special populations:
If you are taking other medications or supplements, inform your healthcare provider before starting Efudex.
Dosing must always be individualized by a qualified healthcare professional.
This article provides educational information about Efudex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
